Quality Matters

FEBRUARY 6, 2025

As more monoclonal antibody (mAb) therapies are developed (1 in 3 new drugs are monoclonal antibodies1) and as patent exclusivity expires, these treatments are becoming more widely available. To understand monoclonal antibody drugs, its necessary to first know a little about how antibodies work in the bodys immune system.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Immunity Immunization Biosimilars 52

Pharmaceutical Technology

JUNE 11, 2025

Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Gilead said it is “committed to working with regulatory authorities to resolve the issues underlying the clinical hold” Credit: Melnikov Dmitriy via Shutterstock. Gilead is considered the leading big pharma in HIV treatments.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Communication Hospitals Packaging 52

Pharmacy Times

JUNE 10, 2025

3 Although meloxicam injection delivers a non-opioid alternative for pain control, it is not recommended as a first-line agent when rapid onset of analgesia is needed due to its delayed onset. June 10, 2025. Accessed June 10, 2025. 2 REFERENCES 1. PR Newswire. Meloxicam: Selective COX-2 inhibition in clinical practice.

Pharmacy Technician 29

Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies Biosimilars 29

Pharmacy Times

JUNE 16, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Febrile neutropenia (FN) remains a serious and common complication of chemotherapy.

Inpatient 26

Inpatient HIV Treatment and Prevention Agents Pharmacy Technician Chemotherapy 26